twiist™ AID system powered by Tidepool expected to launch Q2 2025 in the U.S. with Abbott’s FreeStyle Libre® 3 Plus sensorMANCHESTER, N.H., March 18, 2025 (GLOBE NEWSWIRE) -- Sequel Med Tech ...

With the FDA’s clearance of the FreeStyle Libre 3 reader, Abbott plans to pursue adding the system to the Medicare list of covered systems as soon as possible, according to the release.

That clearance gives users of the FreeStyle Libre 3—Abbott’s newest CGM, which itself was cleared by the FDA last May —the option to decide whether they’d prefer to use either the Abbott ...

The study data showed that Abbott's FreeStyle Libre 3 system has an overall MARD of 7.9%, making it the first and only 14-day CGM system to achieve a MARD of less than 8%.